Adaptive urn designs for estimating several percentiles of a dose-response curve

Statistics in Medicine

Volumn 23, Issue 13, 2004, Pages 2137-2150

  Mugno, Raymond ^a   Zhus, Wei ^b   Rosenberger, William F ^c,d  

^a SOUTHERN CONNECTICUT STATE UNIVERSITY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Adaptive design; c optimal design; Dose response experiment; Generalized P lya urn; Non parametric design

Indexed keywords

ARTICLE; BIOSTATISTICS; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DOSE RESPONSE; EXPERIMENTAL DESIGN; HUMAN; KINESTHESIA; MAXIMUM LIKELIHOOD METHOD; MONTE CARLO METHOD; NEUROLOGIC DISEASE; NONPARAMETRIC TEST; PROCESS OPTIMIZATION; PSYCHOPHYSICS; SENSORY STIMULATION; STATISTICAL ANALYSIS; THEORETICAL STUDY; VALIDATION PROCESS;

DOSE-RESPONSE RELATIONSHIP, DRUG; GUIDELINES; LIKELIHOOD FUNCTIONS; PSYCHOPHYSICS; UNITED STATES;

EID: 3242786541     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.1808     Document Type: Article

References (33)

1. Yano BL, Bond DM, Novilla MN, McFadden LG, Reasor MJ. Spinosad insecticide: subchronic and chronic toxicity and lack of carcinogenicity in Fischer 344 rats. Toxicological Sciences 2002; 65:288-298.
2. Braida D, Sala M. Eptastigmine: ten years of pharmacology, toxicology, pharmacokinetic, and clinical studies. Central Nervous System Drug Review 2001; 7:369-386.
3. Zajecka J, McEnany GW, Lusk KM. Antidepressant dosing and switching guidelines: focus on nefazodone. Journal of Clinical Psychiatry 2002; 63:42-47.
4. Duetsch G, Illig T, Loesgen S, Rohde K, Klopp N, Herbon N, Gohlke H, Altmueller J, Wjst M. STAT6 as an asthma candidate gene: polymorphism-screening, association and haplotype analysis in a Caucasian sib-pair study. Human Molecular Genetics 2002; 11:613-621.
5. Body S, Chiang TJ, Mobini S, Ho MY, Bradshaw CM, Szabadi E. Failure of central 5-hydroxytryptamine depletion to alter the effect of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on timing performance on the free-operant psychophysical procedure. Psychopharmacology (Berlin) 2001; 158(1):305-313.
6. Prescott J, Stevenson RJ. Desensitization to oral zingerone irritation: effects of stimulus parameters. Physiology and Behavior 1996; 60:1473-1480.
7. Dixon WJ, Mood AM. A method for obtaining and analyzing sensitivity data. Journal of the American Statistical Association 1948; 43:109-126.
8. Cochran WG, Davis M. The Robbins-Monro method for estimating the median lethal dose. Journal of the Royal Statistical Society B 1965; 27:28-44.
9. Freeman PR. Optimal Bayesian sequential estimation of the median effective dose. Biometrika 1970; 57:79-89.
10. Zhu W, Wong WK. Multiple-objective designs in a dose response experiment. Journal of Biopharmaceutical Statistics 2000; 10:1-14.
11. O'Quigley J, Pepe M, Fisher L. Continual reassessment method: a practical design for Phase I clinical trials in cancer, Biometrics 1990; 46:33-48.
12. Zeng Q, Zhu W, Wong WK. Dual-objective Bayesian optimal designs for a dose-ranging study. Drug Information Journal 2000; 34:421-428.
13. Kpamegan EE, Flournoy, N. An optimizing up down design. In Optimum Design, Atkinson AC, Bogacka B, Zhigljavski A (eds). Kluwer Academic Publishers: The Netherlands, 2001; 211-224.
14. Braun T. The bivariate continual reassessment method: extending the CRM to phase I trials of two competing outcomes. Controlled Clinical Trials 2002; 23:240-256.
15. O'Quigley J, Hughes M, Fenton T. Dose finding designs for HIV studies. Biometrics 2001; 57:1018-1029.
16. Hardwick J, Meyer MC, Stout QF. Directed walk designs for dose response problems with competing failure modes. Biometrics 2003; 59:229-236.
17. Thall P, Russell K. A strategy for dose-finding and safety monitoring based on efficacy and adverse outcomes in pase I/II clinical trials. Biometrics 1998; 54:251-264.
18. Kalish L. Efficient design for estimation of median lethal dose and quantal dose-response curves. Biometrics 1990; 46:737-748.
19. Rosenberger WF, Grill SE. A sequential design for psychophysical experiments: an application to estimating timing of sensory events. Statistics in Medicine 1997; 16:2245-2260.
20. Zhu W, Wong WK. Bayesian optimal designs for estimating a set of symmetrical quantiles. Statistics in Medicine 2001; 20:123-137.
21. Rosenberger WF, Lachin JM. The use of response-adaptive designs in clinical trials. Controlled Clinical Trials 1993; 14:471-484.
22. Robbins H, Monro, S. A stochastic approximation method. Annals of Mathematical Statistics 1951; 22:400-407.
23. Wetherill GB. Sequential estimation of quantal response curves. Journal of the Royal Statistical Society B 1963; 25:1-48.
24. Durham SD, Flournoy N. Convergence results for an adaptive ordinal urn design. Journal of Theory of Probability and Applications 1993; 37:14-17.
25. Athreya KB, Ney, PE. Branching Processes. Springer: New York, 1972; 218-225.
26. Grill SE, Rosenberger WF, Boyle K, Cannon M, Hallet M. Perception of timing of a kinesthetic stimuli. NeuroReport 1998; 9:4001-4005.
27. Flournoy N. A biased coin urn design for estimating a target quantile from a sequence of binary responses: asymptotic results. Proceedings of the 20th International Conference on Information Technology Interfaces, 1998; 13-18.
28. Mugno RA. Comparison of adaptive designs for estimating several percentiles of a dose-response curve. Doctoral Dissertation, State University of New York at Stony Brook, New York, 2001.
29. Rosenberger WF, Flournoy N, Durham S. Asymptotic normality of maximum likelihood estimators from multiparameter response driven designs. Journal of Statistical Planning and Inference 1997; 60:69-76.
30. Durham SD, Flournoy N. Random walks for quantile estimation. In Statistical Decision Theory and Related Topics, Berger J, Gupta S (eds). Springer: New York, 1994; 467-476.
31. Dai Z, Zhu W. Locally compound optimal designs. State University of New York at Stony, Department of Applied Mathematics and Statistics Technical Report; 02-18, 2002.
32. Chaloner K, Larntz K. Optimal Bayesian design applied to logistic regression experiments. Journal of Statistical Planning and Inference 1989; 21:191-208.
33. Zhu W. On the optimal designs of multiple-objective clinical trials and quantal dose-response experiments. Doctoral Dissertation, University of California, Los Angeles, 1996.